Chief Medical Editor Peter Kaiser, MD, will interview key retina surgeons regarding their clinical experience and honest conversations on managing patients during COVID, ensuring adherence to treatment regimens, how they talk to patients and handling durability during the pandemic.
Listen Now
Episode 13: Key Findings from Recent Protocols for DRCR
Peter Kaiser, MD and Judy Kim, MD discuss DRCR and key findings from recent protocols.
Episode 12: Treatment of Non-proliferative Diabetic Retinopathy in the Absence of DME
Peter Kaiser, MD and Yasha Modi, MD discuss treatment of non-proliferative diabetic retinopathy in the absence of diabetic macular edema.
Episode 11: The Treatment of Diabetic Retinopathy
Peter Kaiser, MD and Caroline Baumal, MD discuss the history and practice of treatment for diabetic retinopathy.
Episode 10: The Port Delivery System and Wet AMD
Peter Kaiser, MD and Carol Regillo, MD, FACS discuss the port delivery system and how it impacts treatment of wet AMD.
Episode 9: Treatment Options in the Covid Era
Peter Kaiser, MD and Christina Weng, MD discuss treatment options in the Covid era, AMD, and the durability of these treatments.
Episode 8: The Challenge of Treating with Persistent Fluid
Peter Kaiser, MD, and Rishi Singh, MD assess treatment goal challenges with persistent fluid, accompanied with inability to extend injection intervals.
Episode 7: Genentech’s New Port Delivery System
Peter Kaiser, MD, and Carl Awh, MD discuss what retina specialists can expect with the new Port Delivery System from Genentech.
Episode 6: Closing Macular Holes
Peter Kaiser, MD, and Tarek S. Hassan, MD, discuss tips and tricks for closing complicated macular holes.
Episode 5: Changes in Diabetic Retinopathy
Peter Kaiser, MD, and Jeffrey Heier, MD, discuss dramatic changes that can influence treatment and care in high risk cases of diabetic retinopathy.
Episode 4: New Therapies and Clinical Trials for AMD
Peter Kaiser, MD, and Rishi Singh, MD, assess new therapies and clinical trials for age-related macular degeneration.
Episode 3: Strategies for Choosing an anti-VEGF Treatment
Peter Kaiser, MD, and Michael Singer, MD, discuss strategies for choosing an anti-VEGF treatment based on patients’ personal needs, how to handle non-responders, and what do to when inflammation is a concern.
Episode 2: Evaluating Safety and Efficacy of Treatment for Wet AMD
Peter Kaiser, MD, and Timothy Murray, MD, MBA, discuss the HAWK and HARRIER phase 3 studies evaluating the safety and efficacy of brolucizumab for wet AMD.
Episode 1: Age-related Macular Degeneration
Peter Kaiser, MD, and Jeffrey Heier, MD, examine the findings of the Novartis-appointed Safety Review Committee’s independent assessment of post-marketing cases of inflammation following the approval of brolucizumab.
Peter Kaiser, MD and Judy Kim, MD discuss DRCR and key findings from recent protocols.
Episode 12: Treatment of Non-proliferative Diabetic Retinopathy in the Absence of DME
Peter Kaiser, MD and Yasha Modi, MD discuss treatment of non-proliferative diabetic retinopathy in the absence of diabetic macular edema.
Episode 11: The Treatment of Diabetic Retinopathy
Peter Kaiser, MD and Caroline Baumal, MD discuss the history and practice of treatment for diabetic retinopathy.
Episode 10: The Port Delivery System and Wet AMD
Peter Kaiser, MD and Carol Regillo, MD, FACS discuss the port delivery system and how it impacts treatment of wet AMD.
Episode 9: Treatment Options in the Covid Era
Peter Kaiser, MD and Christina Weng, MD discuss treatment options in the Covid era, AMD, and the durability of these treatments.
Episode 8: The Challenge of Treating with Persistent Fluid
Peter Kaiser, MD, and Rishi Singh, MD assess treatment goal challenges with persistent fluid, accompanied with inability to extend injection intervals.
Episode 7: Genentech’s New Port Delivery System
Peter Kaiser, MD, and Carl Awh, MD discuss what retina specialists can expect with the new Port Delivery System from Genentech.
Episode 6: Closing Macular Holes
Peter Kaiser, MD, and Tarek S. Hassan, MD, discuss tips and tricks for closing complicated macular holes.
Episode 5: Changes in Diabetic Retinopathy
Peter Kaiser, MD, and Jeffrey Heier, MD, discuss dramatic changes that can influence treatment and care in high risk cases of diabetic retinopathy.
Episode 4: New Therapies and Clinical Trials for AMD
Peter Kaiser, MD, and Rishi Singh, MD, assess new therapies and clinical trials for age-related macular degeneration.
Episode 3: Strategies for Choosing an anti-VEGF Treatment
Peter Kaiser, MD, and Michael Singer, MD, discuss strategies for choosing an anti-VEGF treatment based on patients’ personal needs, how to handle non-responders, and what do to when inflammation is a concern.
Episode 2: Evaluating Safety and Efficacy of Treatment for Wet AMD
Peter Kaiser, MD, and Timothy Murray, MD, MBA, discuss the HAWK and HARRIER phase 3 studies evaluating the safety and efficacy of brolucizumab for wet AMD.
Episode 1: Age-related Macular Degeneration
Peter Kaiser, MD, and Jeffrey Heier, MD, examine the findings of the Novartis-appointed Safety Review Committee’s independent assessment of post-marketing cases of inflammation following the approval of brolucizumab.